Data for 57 patients with stage IIIB/IV lung EGFR-mutated adenocarcinoma treated between May 2015 and July 2019 were retrieved and analyzed, and the baseline characteristics and treatment information of these patients are shown in Table 1. Here, EGFR is linked to adenocarcinoma.